(MENAFN- EIN Presswire) EINPresswire/ -- The global hard gelatin capsules market is poised for substantial growth, projected to reach USD 3.46 billion by 2035, up from USD 2.05 billion in 2025, registering a compound annual growth rate (CAGR) of 5.8%. The surge is driven by rising demand for oral solid dosage forms in both pharmaceutical and nutraceutical sectors, along with advances in encapsulation technology and increasing consumer preference for convenient, effective delivery systems.

Hard gelatin capsules are favored for their ease of swallowing, rapid dissolution, and compatibility with a wide range of active pharmaceutical ingredients (APIs). Aging populations and the prevalence of chronic diseases worldwide are further accelerating the adoption of these capsules as safe and efficient delivery vehicles.

Explore trends before investing - request a sample report today!:-

Regional Growth Insights

Asia Pacific is expected to experience the fastest growth over the next decade, supported by increasing generic drug manufacturing, expanding healthcare access, and government initiatives in countries like India and China. China alone is projected to grow at a CAGR of 5.8% from 2025 to 2035, driven by rising over-the-counter (OTC) medication use and health-conscious consumer trends.

In North America, the USA continues to dominate, holding an estimated 80.6% market share, with growth fueled by the personalized medicine trend. Customized formulations and patient-centric approaches are encouraging the use of hard gelatin capsules for targeted therapies and optimized drug delivery.

Europe, led by Germany, is witnessing steady demand due to consumers' preference for capsules that mask taste and are easier to swallow. Germany's market is projected to grow at a CAGR of 1.8% through 2035, reflecting strong acceptance of capsule-based supplements and prescription medications among aging populations.

The Middle East, particularly Saudi Arabia, is emerging as a strategic market, where halal-certified gelatin capsules are gaining traction, aligning with cultural and regulatory requirements.

Market Dynamics and Investment Highlights

Type-B gelatin capsules, derived from animal bones and calf skin, dominate the global market with a 46.7% share, favored for cost-effectiveness, structural integrity, and regulatory acceptance in halal and kosher markets. Size“0” capsules remain the most widely used due to their optimal balance between fill capacity and swallowability, particularly in nutraceuticals, herbal supplements, and over-the-counter medications.

Technological advancements in capsule sealing, liquid-filled formulations, microencapsulation, and banding techniques are improving product safety, bioavailability, and production efficiency. Plant-based and non-animal gelatin alternatives are also expanding market opportunities for vegetarian and halal consumers.

The hard gelatin capsules market benefits from rising nutraceutical demand, with dietary supplements like fish oil and herbal blends increasingly delivered in capsule form due to stability, taste masking, and precise dosing. With preventive healthcare on the rise, these capsules are expected to capture growing consumer preference globally.

Click Here to Purchase the Report:-

Competitive Landscape

Tier 1 companies, including ACG Worldwide, Lonza-Capsugel, Qualicaps, and Suheung Co., collectively account for 58.5% of the market, leveraging high production capacity, extensive geographic reach, and diversified product portfolios. Mid-tier and smaller manufacturers focus on regional markets, niche products, and technological innovation to gain competitive advantage.

Future Outlook

The global hard gelatin capsules market is expected to maintain steady growth across all key regions, driven by innovation, regulatory compliance, and rising consumer demand for convenience, safety, and efficacy. Asia Pacific will be the fastest-growing region, while the USA and Europe remain critical for high-value, technologically advanced products. Increasing investments in sustainable sourcing, R&D, and personalized medicine solutions are projected to sustain market expansion through 2035.

As pharmaceutical and nutraceutical companies continue to optimize drug delivery and enhance patient compliance, hard gelatin capsules are set to solidify their position as a preferred dosage form worldwide.

Latest Pharmaceuticals Reports:-

Long-acting PEG-rhG-CSF Market

Radiopharmaceutical Dispensing System Market

Caprolactam Market

Why Choose FMI Empowering Decisions that Drive Real-World Outcomes:-

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analystsworldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries:...
Website:
LinkedIn| Twitter| Blogs | YouTube

MENAFN11112025003118003196ID1110326181